Evidence map›Paper›PMID 21552537›Full record

ArticlePloS one2011

RhoE deficiency produces postnatal lethality, profound motor deficits and neurodevelopmental delay in mice.

Enric Mocholí, Begoña Ballester-Lurbe, Gloria Arqué, Enric Poch, Blanca Peris, Consuelo Guerri, Mara Dierssen, Rosa M Guasch, José Terrado, Ignacio Pérez-Roger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. NMJ-related diseases beyond the congenital myasthenic syndromes.Frontiers in cell and developmental biology · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Genetic deletion ofOncotarget · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Rnd3 as a Novel Target to Ameliorate Microvascular Leakage.Journal of the American Heart Association · 2016
    Article
  13. Pathophysiological Functions of Rnd3/RhoE.Comprehensive Physiology · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Enric MocholíDepartment of Chemistry, Biochemistry and Molecular Biology, School of Health Sciences, Universidad CEU Cardenal Herrera, Moncada, Valencia, Spain.
Begoña Ballester-Lurbe
Gloria Arqué
Enric Poch
Blanca Peris
Consuelo Guerri
Mara Dierssen
Rosa M Guasch
José Terrado
Ignacio Pérez-Roger
Universidad Cardenal Herrera CEU · ESCentro de Investigacion Principe Felipe · ESBarcelona Biomedical Research Park · ESCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rnd proteins are a subfamily of Rho GTPases involved in the control of actin cytoskeleton dynamics and other cell functions such as motility, proliferation and survival. Unlike other members of the Rho family, Rnd proteins lack GTPase activity and therefore remain constitutively active. We have recently described that RhoE/Rnd3 is expressed in the Central Nervous System and that it has a role in promoting neurite formation. Despite their possible relevance during development, the role of Rnd proteins in vivo is not known. To get insight into the in vivo function of RhoE we have generated mice lacking RhoE expression by an exon trapping cassette. RhoE null mice (RhoE gt/gt) are smaller at birth, display growth retardation and early postnatal death since only half of RhoE gt/gt mice survive beyond postnatal day (PD) 15 and 100% are dead by PD 29. RhoE gt/gt mice show an abnormal body position with profound motor impairment and impaired performance in most neurobehavioral tests. Null mutant mice are hypoactive, show an immature locomotor pattern and display a significant delay in the appearance of the hindlimb mature responses. Moreover, they perform worse than the control littermates in the wire suspension, vertical climbing and clinging, righting reflex and negative geotaxis tests. Also, RhoE ablation results in a delay of neuromuscular maturation and in a reduction in the number of spinal motor neurons. Finally, RhoE gt/gt mice lack the common peroneal nerve and, consequently, show a complete atrophy of the target muscles. This is the first model to study the in vivo functions of a member of the Rnd subfamily of proteins, revealing the important role of Rnd3/RhoE in the normal development and suggesting the possible involvement of this protein in neurological disorders.

Indexed as

AnimalsAnimals, NewbornGene DeletionGrowth DisordersMiceMotor ActivityNervous SystemNeuromuscular DiseasesPeroneal Nerverho GTP-Binding ProteinsSurvival Analysisrho GTP-Binding ProteinsRnd3 protein, mouse

Identifiers

PMID21552537
PMCPMC3084285
OpenAlexW1986504117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.